Student Oral Presentations Session I

Monday, April 24, 2023

2:15 PM – 3:45 PM GMT

Moderator(s)

Lisa Pont, PhD

Professor of Pharmacy
Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia, Australia
Sebastian Jugl, BPharm, RPh (he/him/his)

PhD Student
University of Florida
Gainesville, Florida, United States

Disclosure(s):

Lisa G. Pont: No financial relationships to disclose

Sebastian Jugl, BPharm, RPh: No financial relationships to disclose

Presentations:

2:15 PM – 3:45 PM GMT

Hormone therapy and risk of venous thromboembolism in transgender women
Presenting Author: Qi Zhang, MSPH (she/her/hers) – Department of Epidemiology, Emory University
Author: Michael Goodman, MD, MPH (he/him/his) – Emory University
2:15 PM – 3:45 PM GMT

Characterizing Fit-for-Purpose Real-World Data: An Assessment of a Mother–Infant Linkage in the Japan Medical Data Center Claims Database
Presenting Author: Julie Barberio (she/her/hers) – Department of Epidemiology, Emory University
Author: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
Author: Ashley I. Naimi, PhD – Department of Epidemiology, Emory University
Author: Rachel E. Patzer, PhD – Department of Epidemiology, Emory University
Author: Christopher Kim, PhD – Center for Observational Research, Amgen Inc.
Author: Timothy L. Lash, DSc – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA USA
2:15 PM – 3:45 PM GMT

Determinants of vaccination and willingness to vaccinate against COVID-19 among pregnant and postpartum women during the third wave of the pandemic: A European Multinational cross-sectional survey
Presenting Author: Emeline Maisonneuve, MD (she/her/hers) – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
Author: Eva Gerbier – Pharmacy department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Author: Fatima Tauqeer – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, , Oslo, Norway
Author: Léo Pomar, PhD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Author: Guillaume Favre, MD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Author: Ursula Winterfeld, PhD – Pharmacy department, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Author: Anneke Passier, PhD – Teratology Information Service, Pharmacovigilance Centre Lareb, ‘s Hertogenbosch, The Netherlands
Author: Alison Oliver, PhD – UKTIS, Newcastle upon Tyne Hospitals, NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tynes, UK
Author: David Baud, MD PhD – Materno-fetal and Obstetrics Research Unit, Woman-Mother-Child department, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Michael Ceulemans, PhD – Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
Author: Alice Panchaud, PhD – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
2:15 PM – 3:45 PM GMT

Distinguishing between indications for use of medications in administrative data sources Application to pregabalin and gabapentin A contribution from the ConcePTION project
Presenting Author: Anna-Belle Beau, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, Toulouse, France
Author: Xavier Moisset – Université Clermont Auvergne, CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand
Author: Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Marie Beslay, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, France.
Author: Claudia C. Bartolini – ARS Toscana
Author: Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
Author: Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea
Author: Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University, Italy
Author: Visa Martikainen – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
Author: Joan K. Morris – St George's, University of London, London
Author: Amanda j. Neville, N/A – Registro IMER University of Ferrara and Azienda Ospedaliero Universitario S Anna, Ferrara, Italy
Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy
Author: Jingping Mo – Worldwide Medical and Safety, Pfizer Inc., New York, NY
Author: Christine Damase-Michel, PhD, PharmD – Université Toulouse III
2:15 PM – 3:45 PM GMT

Preventative association of antidepressant treatment in pregnant women with eating disorders on antenatal mental outcomes- results from the Norwegian Mother, Father, and Child Cohort Study
Presenting Author: Milica Zugic, MScPharm – Department of Pharmacy, University of Oslo, Oslo, Norway
Author: Nhung Trinh, PhD – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo
Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
2:15 PM – 3:45 PM GMT

Prenatal exposure to antipsychotic medication and neurocognitive impairment among children: A Nordic cohort study
Presenting Author: Claudia Bruno, BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
Author: Vidar Hjellvik, PhD – Norwegian Institute of Public Health
Author: Sinna Pilgaard Ulrichsen, MSc (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
Author: Marte-Helene h. Bjørk, MD, PhD – NorHEAD Norwegian Centre for Headache Research, Department of Clinical Medicine, University of Bergen, Bergen, Norway Jonas Lies vei 87 5021, Bergen Norway
Author: Buket Öztürk Esen, MSc – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
Author: Malcolm B. Gillies, PhD (he/him/his) – School of Population Health, University of New South Wales
Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
Author: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
Author: Pär Karlsson, MSc (he/him/his) – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health
Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
Author: Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
Author: Sallie-Anne Pearson, PhD – School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
Author: Hein Stigum, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Author: Kari Furu, PhD – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
Author: Jacqueline Cohen, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Author: Helga Zoega – University of New South Wales - Sydney